DaVita HealthCare Partners Inc (DVA) Stock Analysis

DaVita HealthCare Partners Inc (DVA) is a publicly traded company in the HEALTHCARE sector. It trades at $187.90, carries a market capitalization of $12.18B, a price-to-earnings ratio of 18.29. This page summarizes the public market data, fundamentals, and frequently asked questions for DVA, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - MEDICAL CARE FACILITIES

Exchange: NYSE

Key Metrics

Market Sentiment

DaVita HealthCare Partners Inc currently has a Bullish sentiment score of 0.21.

About DaVita HealthCare Partners Inc

DaVita HealthCare Partners Inc. is a premier provider of kidney care services, renowned for its expansive network of outpatient dialysis centers throughout the United States. The company is dedicated to enhancing the quality of life for patients with chronic kidney disease by utilizing cutting-edge treatment technologies and innovative care delivery models. As a leader in the renal care sector, DaVita's integrated approach significantly improves patient outcomes, positioning it as a compellin...

GNG Research Analysis

GNG Research scores DaVita HealthCare Partners Inc (DVA) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for DVA.

Frequently Asked Questions

Does DVA pay dividends?

DaVita HealthCare Partners Inc (DVA) does not currently pay a regular dividend.

What is DVA's P/E ratio?

DaVita HealthCare Partners Inc has a price-to-earnings (P/E) ratio of 18.29.

What is DVA's market cap?

DaVita HealthCare Partners Inc (DVA) has a market capitalization of $12.18B with a current stock price of $187.90.